CTI BioPharma to Present at Upcoming Investor Conferences

SEATTLE, March 9, 2018

30^th Annual Roth Conference in Laguna Niguel, CA
Date: Monday, March 12, 2018
Time: 8:30PM ET / 5:30PM PT

Oppenheimer 28^th Annual Healthcare Conference in New York, NY
Date: Tuesday, March 20, 2018
Time: 10:55AM ET / 7:55AM PT

17^th Annual Needham Healthcare Conference in New York, NY
Date: Wednesday, March 28, 2018
Time: 10:00AM ET / 7:00AM PT

The presentations will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.

About CTI BioPharma Corp.

CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. CTI BioPharma has a late-stage development pipeline, including pacritinib for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington. For additional information and to sign up for email alerts and get RSS feeds, please visit www.ctibiopharma.com.